Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F L Giesel

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Molecular Imaging and Biology|August 23, 2022
Distinguishing Benign and Malignant Findings on [<sup>68</sup> Ga]-FAPI PET/CT Based on Quantitative SUV MeasurementsM Dabir, E Novruzov, K Mattes-György, et al.
AJNR. American Journal of Neuroradiology|August 16, 2006
Temporal horn index and volume of medial temporal lobe atrophy using a new semiautomated method for rapid and precise assessmentF L Giesel, H K Hahn, P A Thomann, et al.
Molecular Imaging and Biology|October 16, 2020
Impact of Primary Staging with Fibroblast Activation Protein Specific Enzyme Inhibitor (FAPI)-PET/CT on Radio-Oncologic Treatment Planning of Patients with Esophageal CancerJ Ristau, F L Giesel, M F Haefner, et al.
Molecular Imaging and Biology|August 23, 2022
Detecting and Locating the Site of Local Relapse Using <sup>18</sup>F-PSMA-1007 Imaging After Primary Treatment of 135 Prostate Cancer Patients-Potential Impact on PSMA-Guided Radiation TherapyS A Koerber, R C Kroener, K Dendl, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 27, 2012
PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesionsA Afshar-Oromieh, A Malcher, M Eder, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 6, 2013
Reply to Reske et al.: PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesionsA Afshar-Oromieh, A Malcher, M Eder, et al.
Neurology|June 28, 2006
Diagnostic performance of spectroscopic and perfusion MRI for distinction of brain tumorsM A Weber, S Zoubaa, M Schlieter, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 21, 2021
Novel FAP ligands enable improved imaging contrast in sarcoma patients due to FAPI-PET/CTStefan A Koerber, R Finck, K Dendl, et al.
Molecular Imaging and Biology|November 12, 2022
PSMA-1007 Uptake in Ganglia of the Sympathetic Trunk and Its Intra-individual ReproducibilityE Mamlins, D Schmitt, M Beu, et al.
Molecular Imaging and Biology|March 29, 2022
Head-to-head Intra-individual Comparison of [<sup>68</sup>Ga]-FAPI and [<sup>18</sup>F]-FDG PET/CT in Patients with Bladder CancerE Novruzov, K Dendl, H Ndlovu, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Molecular Imaging and Biology|August 23, 2022
Distinguishing Benign and Malignant Findings on [<sup>68</sup> Ga]-FAPI PET/CT Based on Quantitative SUV MeasurementsM Dabir, E Novruzov, K Mattes-György, et al.
AJNR. American Journal of Neuroradiology|August 16, 2006
Temporal horn index and volume of medial temporal lobe atrophy using a new semiautomated method for rapid and precise assessmentF L Giesel, H K Hahn, P A Thomann, et al.
Molecular Imaging and Biology|October 16, 2020
Impact of Primary Staging with Fibroblast Activation Protein Specific Enzyme Inhibitor (FAPI)-PET/CT on Radio-Oncologic Treatment Planning of Patients with Esophageal CancerJ Ristau, F L Giesel, M F Haefner, et al.
Molecular Imaging and Biology|August 23, 2022
Detecting and Locating the Site of Local Relapse Using <sup>18</sup>F-PSMA-1007 Imaging After Primary Treatment of 135 Prostate Cancer Patients-Potential Impact on PSMA-Guided Radiation TherapyS A Koerber, R C Kroener, K Dendl, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 27, 2012
PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesionsA Afshar-Oromieh, A Malcher, M Eder, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 6, 2013
Reply to Reske et al.: PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesionsA Afshar-Oromieh, A Malcher, M Eder, et al.
Neurology|June 28, 2006
Diagnostic performance of spectroscopic and perfusion MRI for distinction of brain tumorsM A Weber, S Zoubaa, M Schlieter, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 21, 2021
Novel FAP ligands enable improved imaging contrast in sarcoma patients due to FAPI-PET/CTStefan A Koerber, R Finck, K Dendl, et al.
Molecular Imaging and Biology|November 12, 2022
PSMA-1007 Uptake in Ganglia of the Sympathetic Trunk and Its Intra-individual ReproducibilityE Mamlins, D Schmitt, M Beu, et al.
Molecular Imaging and Biology|March 29, 2022
Head-to-head Intra-individual Comparison of [<sup>68</sup>Ga]-FAPI and [<sup>18</sup>F]-FDG PET/CT in Patients with Bladder CancerE Novruzov, K Dendl, H Ndlovu, et al.
Pageof 6